Breaking Up Isn't Hard to Do: Isolating Cell-free DNA Fragments in Osteosarcoma

Daniel A. Weiser; Masanori Hayashi; Mark A. Applebaum

doi:10.1158/1078-0432.CCR-23-0390

Breaking Up Isn't Hard to Do: Isolating Cell-free DNA Fragments in Osteosarcoma

Daniel A. Weiser, Masanori Hayashi, Mark A. Applebaum

Pediatrics

Research output: Contribution to journal › Article › peer-review

Abstract

The novel use of blood-based biospecimens from a retrospective cohort of 50 patients with osteosarcoma was recently studied. The potential clinical utility of sorting cell-free DNA by fragment size was defined, with shorter tumor-specific DNA enrichment providing prognostic value and allowing for streamlined molecular profiling of circulating tumor material.

Original language	English (US)
Pages (from-to)	2017-2019
Number of pages	3
Journal	Clinical Cancer Research
Volume	29
Issue number	11
DOIs	https://doi.org/10.1158/1078-0432.CCR-23-0390
State	Published - Jun 1 2023

ASJC Scopus subject areas

General Medicine

Access to Document

10.1158/1078-0432.CCR-23-0390

Cite this

@article{94f58028c6b9462b8af6d812d7eb31bb,

title = "Breaking Up Isn't Hard to Do: Isolating Cell-free DNA Fragments in Osteosarcoma",

abstract = "The novel use of blood-based biospecimens from a retrospective cohort of 50 patients with osteosarcoma was recently studied. The potential clinical utility of sorting cell-free DNA by fragment size was defined, with shorter tumor-specific DNA enrichment providing prognostic value and allowing for streamlined molecular profiling of circulating tumor material.",

author = "Weiser, {Daniel A.} and Masanori Hayashi and Applebaum, {Mark A.}",

year = "2023",

month = jun,

day = "1",

doi = "10.1158/1078-0432.CCR-23-0390",

language = "English (US)",

volume = "29",

pages = "2017--2019",

journal = "Clinical Cancer Research",

issn = "1078-0432",

publisher = "American Association for Cancer Research Inc.",

number = "11",

}

TY - JOUR

T1 - Breaking Up Isn't Hard to Do

T2 - Isolating Cell-free DNA Fragments in Osteosarcoma

AU - Weiser, Daniel A.

AU - Hayashi, Masanori

AU - Applebaum, Mark A.

PY - 2023/6/1

Y1 - 2023/6/1

N2 - The novel use of blood-based biospecimens from a retrospective cohort of 50 patients with osteosarcoma was recently studied. The potential clinical utility of sorting cell-free DNA by fragment size was defined, with shorter tumor-specific DNA enrichment providing prognostic value and allowing for streamlined molecular profiling of circulating tumor material.

AB - The novel use of blood-based biospecimens from a retrospective cohort of 50 patients with osteosarcoma was recently studied. The potential clinical utility of sorting cell-free DNA by fragment size was defined, with shorter tumor-specific DNA enrichment providing prognostic value and allowing for streamlined molecular profiling of circulating tumor material.

UR - http://www.scopus.com/inward/record.url?scp=85160967038&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85160967038&partnerID=8YFLogxK

U2 - 10.1158/1078-0432.CCR-23-0390

DO - 10.1158/1078-0432.CCR-23-0390

M3 - Article

C2 - 36976253

AN - SCOPUS:85160967038

SN - 1078-0432

VL - 29

SP - 2017

EP - 2019

JO - Clinical Cancer Research

JF - Clinical Cancer Research

IS - 11

ER -

Breaking Up Isn't Hard to Do: Isolating Cell-free DNA Fragments in Osteosarcoma

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this